Clinical Trial Update: Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy [NA]

View source ↗

Summary

This clinical trial update reports the completion of a prospective natural history study of patients with spinal muscular atrophy type 2 and type 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy Type
• Spinal Muscular Atrophy Type 2

Snippet

Sponsor: Institut de Myologie, France | Conditions: Type 2 Spinal Muscular Atrophy, Type 3 Spinal Muscular Atrophy | NA | Status: COMPLETED